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Aluminium-based adjuvants (ABA) are the predominant adjuvants used in human vaccinations. While a
consensus is yet to be reached on the aetiology of the biological activities of ABA several studies have
identified shape, crystallinity and size as critical factors affecting their adjuvanticity. In spite of recent
advances, the fate of ABA following their administration remains unclear. Few if any studies have
demonstrated the unequivocal presence of intracellular ABA. Herein we demonstrate for the first time the
unequivocal identification of ABA within a monocytic T helper 1 (THP-1) cell line, using lumogallion as a
fluorescent molecular probe for aluminium. Use of these new methods revealed that particulate ABA was
only found in the cell cytoplasm. Transmission electron microscopy revealed that ABA were contained
within vesicle-like structures of approximately 0.5–1 mm in diameter.
S
ince their inception in the 1920s aluminium based adjuvants (ABA) have remained the predominantly used
adjuvants in human vaccinations1. ABA are aluminium salts dispersed in water to form heterogeneous
suspensions or gels, of hydrated colloid particles that consist of micron-sized aggregates of 1–20 mm with
primary particles in the nano-size range2–4. Aluminium oxyhydroxide (AlO(OH)) adjuvants such as the licensed
ABA AlhydrogelH (Brenntag Biosector, Denmark)5 are the most commonly used manufactured ABA in clinical
vaccinations. AlO(OH)-based adjuvants are principally used owing to being themost well-defined and consistent
of the clinically approved ABA and in their ability to adsorb negatively charged protein antigens from aqueous
solutions at physiological pH2.
When formulated in vaccine preparations, ABA both potentiate the efficacy of weak antigens and shape the
resultant immune response6. Use of antigen only often results in weak immunopotentiation and little or no
antibody production7. Whilst the efficacy of ABA is undisputed, a consensus is yet to be reached upon their
biological activities in vivo. ABA including aluminium hydroxide preparations are used in vaccinating against
diphtheria, hepatitis A and B and against human papilloma virus (HPV) to prevent cervical cancers6,7. An ever
intensifying research effort is currently underway to explain the observed adjuvanticity of ABA with several
studies highlighting their physicochemical properties as a key determinant. Interestingly it has been shown that
nanoparticles of aluminium hydroxide of ca 200 nm elicit more potent adjuvant activities in an in vivomodel of
murine adjuvanticity, than larger particles in the micron-size range9. The increased adjuvanticity of aluminium
hydroxide nanoparticles was explained by their greater ease of uptake by dendritic antigen presenting cells
(APCs)9.
Variation of the physicochemical properties of AlO(OH)-based adjuvants via engineering particles with
defined shape, size and morphology characteristics has been used in studying their immunopotentiating prop-
erties10. Recent research by Sun and co-workers (2013) showed that the design of ordered rod-like AlO(OH)
nanoparticles with higher crystallinity resulted in greater cellular uptake of the antigen and increased IL-1b
production10. Interestingly, increased production of IL-12 and IL-6 was observed in bone marrow-derived
dendritic cells (BMDCs) for the engineered AlO(OH) nanorods, the former being a known polariser of a Th1
response7. Therefore alteration of the physicochemical properties of aluminium hydroxide based adjuvants alone
has been shown to shape their immunostimulatory properties both in vivo and in vitro9,10.
Surprisingly, little experimental information has eluded to the potential cellular uptake of ABA or any com-
partmentalisation of ABA, inside the cell3,11–15. This has been suggested to be critical for the activation and
assembly of the Nalp3 inflammasome, driving pro-inflammatory immune responses via secretion of mature
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interleukin IL-1b and IL-18 cleaved from the prointerleukins by
actvated caspase-116,17. Ultrastructural investigations paired with X-
ray microanalysis have previously been used to successfully confirm
the presence of aluminium in the skin13.
Aluminium hydroxide granulomas from excised subcutaneous
nodules were identified in three children ranging in age from 18 to
36 months following injection of a diphtheria, tetanus and pertussis
vaccine, adjuvanted with aluminium hydroxide13. Whilst aluminium
was identified in the skin the aluminium signal measured was not
confined to any intracellular environment and hence evidence of
intracellular aluminium was neither inferred by the authors nor
could it be established unequivocally13.
Further X-ray based methods have used particle-induced X-ray
emission (PIXE) to identify aluminium in quadriceps muscle of
Cynomolgus monkeys, following intramuscular administration of
a Diphtheria-tetanus vaccine containing 0.6 mg/mL of either
AlO(OH) or aluminium hydroxyphosphate (AlPO4) based adju-
vants14. Increases in the aluminium concentration were found at a
muscular level over scanned areas of 1 mm2 in the injection site, with
marked increases identified in muscular lesions following 3 and 6
months post-injection14. No results were included however to show
that aluminium was localised within cells.
A study by Rimaniol and co-workers (2004) demonstrated the
presence of crystalline inclusions in macrophages exposed to 2 mg/
mL aluminium oxyhydroxide (AlO(OH)) adjuvant via transmission
electron microscopy (TEM)15. Electron micrographs revealed elec-
tron dense material scattered throughout macrophages. In spite of
the observations of electron densematerial inmacrophages, no direct
evidence was provided to confirm that those inclusions identified
contained particulate AlO(OH)15. A more recent study by Lu &
HogenEsch (2013) highlighted the presence of an ABA
(RehydragelTM HPA, USA) in murine macrophages using morin
(2,3,4,5,7-pentahydroxy- flavone) staining11.
An earlier investigation using the same method found ABA inter-
nalised in epithelioid macrophages and multinucleated giant cells in
rhesus macaque skin sections12. No autofluorescence controls were
shown in either paper however and the influences of the protein
antigens alone were not addressed11,12. Morin is also known to bind
to magnesium (Mg21) and calcium (Ca21) ions to produce false
positives18. A hydrochloric acid pre-rinse, prior to staining is fre-
quently used to account for such. The resultant acidity however, is
likely to promote the formation of soluble Al31 increasing the like-
lihood of the dissolution of aluminium bound in tissue and its pos-
sible migration throughout the tissue19.
Investigations monitoring the potential cellular uptake of ABA
have preferentially labelled the adsorbed protein antigen (often oval-
bumin (OVA)) with the amine-reactive derivative of the fluorescein
dye, fluorescein isothiocyanate (FITC)9,10,20,21. Following adsorption
of an ABAwith FITC-labelled OVA, the presence of the adjuvant has
been inferred intracellularly in cultured DC-lines by use of confocal
microscopy20,21, fluorescence microscopy9 and flow cytometry10,20,21.
Whilst the presence of the OVA protein antigen has been observed
intracellularly within APCs9,20,21, whether the adsorbed ABA is inter-
nalised or not remains to be determined as the use of FITC only
allows for the identification of internalised antigen.
Pre-labelling AlO(OH) adjuvants with FITC via the use of pre-
incubation with organic moieties10 may also result in changes to the
surface of the particulates as well as modifications to their hydroxyl
functionality and size. This may in turn affect their uptake as the
variation of such physicochemical properties of ABAhas been shown
to dramatically affect their cellular uptake8,9,10. Furthermore, poten-
tial modifications to the endocytic/phagocytic pathways of interna-
lisation following conjugation of the ABA to FITC-OVA cannot be
ruled out.
Use of AlO(OH) (Alhydrogel, Brenntag) formulated with the chi-
maeric Ealpha green fluorescent protein (EaGFP) demonstrated an
increase in antigen uptake compared to uptake of EaGFP alone via
the detection of GFP using flow cytometry22. As with the use of FITC
only the presence of the antigen could be inferred inside the cell of
which the authors summarised that ABA provide an enhanced deliv-
ery mechanism of the antigen only whilst not addressing potential
uptake of the adjuvant by dendritic cells (DCs)22. Additional studies
have supported these conclusions with crystals of the ABA being
suggested to not enter the cell and rather aid in the transport of
the antigen across DC membranes with activation of the Nalp3
inflammasome being dispensable for triggering subsequent immune
responses23.
Few if any studies within the literature have therefore shown the
direct monitoring of the intracellular ABA content of various
immune cells and a consensus upon the biological activates of
ABA has yet to be reached16,17. Herein we report for the first time
the unequivocal identification of intracellular AlO(OH) particles
both for a clinically approved and an experimental AlO(OH)-based
adjuvant in a monocytic T-helper 1 (THP-1) cell line. Positive iden-
tification of particulate ABA was observed intracellularly by use of
the planar tridentate ligand lumogallion [4-chloro-3-(2,4-dihydrox-
yphenylazo)-2-hydroxybenzene-1-sulphonic acid] as a fluorescent
molecular probe for aluminium24.
Lumogallion is commonly used to detect the presence of alu-
minium at low concentrations in natural waters with a limit of detec-
tion of ca 2 nM25 and has been used extensively for the identification
of themetal ion in plant roots26,27. Lumogallion has been suggested to
act as a planar tridentate ligand for aluminium with binding of the
metal ion via the two phenolic oxygen ions and the azo (N5N) group
of lumogallion establishing a 151 stoichiometry of the complex24.
Lumogallion is known to bind to the soluble ionic Al31 form of
aluminium, with complex formation resulting in an emission intens-
ity at ca 590 nm (orange fluorescence) upon an excitation wave-
length of ca 500 nm28.
Unlike morin, lumogallion is not known to be prone to false posi-
tives including metal ions commonly found in physiological media
including magnesium, calcium24 and iron25. In combination with
fluorescencemicroscopy, use of the complementary techniques, con-
focal microscopy and TEM further aided to confirm the intracellular
presence of particulate aluminium at a physiologically relevant pH,
furthering our understanding into the role of ABA in clinical
vaccinations.
Methods
Cell culture and fixation. All chemicals were from Sigma Aldrich, UK, unless
otherwise stated. THP-1 cells (ATCC TIB-202, LGC Standards, UK) were cultured in
complete R10 medium which consisted of RPMI 1640 medium supplemented with
10% foetal calf serum (EU grade) and 100 mg/mL gentamicin (both from PAA
laboratories, Linz, Austria). All cells were cultured at 37uC in a humidified
atmosphere containing 5% CO2.
Native THP-1 cells (i.e. those containing no ABA) were cultured in the presence of
complete R10medium only, whilst those cell treatments containing the ABAwere co-
cultured in R10 media containing 50 or 200 mg/mL of either the aluminium oxy-
hydroxide-based (AlO(OH)) adjuvant, AlO(OH)Sigma (A8222, aluminium hydroxide
gel colloidal suspension, Sigma Aldrich, UK) or Brenntag’s AlhydrogelH (2%),
AlO(OH)Brenntag (Brenntag Biosector, Denmark) for 24 h. Each of the cell treatments
were cultured in triplicate in 96 well plates with a final volume of 200 mL per well.
Following incubation the triplicatesmade from each of the co-culture conditionswere
pooled and the cells were subsequently centrifuged and washed with phosphate
buffered saline (PBS).
Cells from each of the treatments were then fixed by transfer into 1% para-
formaldehyde (PFA) and incubating for 24 h, at ambient temperature. The number of
intact cells after fixation was counted using an Accuri C6 flow cytometer. After
counting, each of the cell treatments were re-suspended in 70% v/v ethanol in order to
prevent over fixation of the cells resulting in the reduced penetration of histochemical
reagents.
Paraffin and resin embedding of THP-1 cells. Full details concerning paraffin and
resin embedding of THP-1 cells for sectioning are detailed in the supplementary
methods. Briefly, PFA fixed THP-1 cells co-cultured in R10medium in the absence or
presence of AlO(OH)Sigma were pre-embedded into agar and dehydrated fully through
an ethanol gradient. For paraffin embedding the resultant agar-cell blocks were
cleared with Histo-Clear and infiltrated with paraffin wax. 2 mm sections were
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 6287 | DOI: 10.1038/srep06287 2
prepared by use of a rotarymicrotome and the agar-cell sectionswere rehydrated back
into ultrapure water prior to staining. THP-1 cells for resin embedding were
dehydrated as above and then gradually infiltrated with Spurr resin. Polymerised
resin blocks were sectioned at 100 nm by use of an automated ultramicrotome.
Cryosectioning. Fixed THP-1 cells co-cultured in complete R10 medium in the
presence or absence of 50 or 200 mg/mL AlO(OH)Brenntag adjuvant (24 h) were
pelleted and mixed with 40 ml Tissue-TekH O.C.T compound, SakuraH Finetek
cryoprotection medium (VWR, Stockholm, Sweden). Cells were then transferred to a
10 3 10 3 5 mm Tissue-TekH CryomoldH (HistoLabH, Gothenburg, Sweden) and
frozen on dry ice. The frozen cells were sectioned at 6 mm using a Leica CM 3050
cryostat and mounted on Menzel SuperFrostH Plus glass slides (VWR, Stockholm,
Sweden). Slides were stored at 280uC until further processing.
Lumogallion staining of cell sections. Agar-cell sections were de-waxed and
rehydrated by transferring the slides in a holder (up to 12 at a time) through 250.0 mL
of the following in glass staining dishes: Histo-Clear for 3 min, fresh Histo-Clear for
1 min, 100% ethanol for 2 min, 95, 70, 50 & 30% v/v ethanol for 1 min and finally
ultrapure water for 35 s. Sides were agitated in each solution and blotted dry on tissue
paper between each stage. Rehydrated cell sections were immediately placed into
either 100 mM lumogallion (TCI Europe N.V. Belgium) buffered in 50 mM PIPES,
pH 7.4 or the PIPES-buffer alone for auto-fluorescence analyses and were then
covered and incubated at ambient temperature in the dark for 24 h.
Following 24 h the slides were removed, blotted dry and for the lumogallion
stained sections only, were rinsed by gentle agitation in 50 mM PIPES, pH 7.4 for
2 min. Slides were rinsed in ultrapure water for 2 min, air dried and finally mounted
using ProLongH Gold Antifade Reagent with 49,6-diamidino-2-phenylindole, dihy-
drochloride (DAPI) (Life Technologies, UK). Slides were stored horizontally for 24 h
at 4uC to allow the mounting media to fully cure, prior to their analysis via fluor-
escence microscopy. Cryosectioned THP-1 cells were thawed for 10 min at ambient
temperature and then placed into either PIPES-buffer alone or PIPES-buffered
lumogallion. Cryosectioned THP-1 cells were stained and mounted in the exact same
way as the agar-cell sections.
Fluorescencemicroscopy. For specific details pertaining to fluorescencemicroscopy,
please refer to the supplementary methods. All cell images were obtained at 31000
magnification using a 3100 Plan-Fluorite oil immersion objective (Olympus, UK) in
combination with low auto-fluorescence immersion oil (Olympus immersion oil
type-F). The exposure settings for the lumogallion analyses were fixed at 1 swith fixed
light transmission values. Images were obtained using the CellD software (Olympus,
Soft Imaging Solutions, GmbH) package and fluorescent and light channels were
overlaid by use of Photoshop (Adobe systems Inc. USA).
Transmission electron microscopy (TEM). Grids were stained with 2% w/v uranyl
acetate as described in the supplementarymethods. Samples for TEMwere viewed on
a JEOL 1230 transmission electron microscope operated at 100.0 kV (spot size 2),
equippedwith aMegaview III digital camera from Soft Imaging Systems (SIS). Images
were obtained on the iTEM universal TEM imaging platform software.
Measurements of intracellular ABA particles were made using the CellD software
package and the final editing of electron micrographs for publication was achieved
using Photoshop (Adobe systems Inc. USA).
Results
Identification of intracellular AlO(OH) particles in THP-1 agar-
cell sections. Preliminary experiments in which ABA only
(AlO(OH)Sigma and AlO(OH)Brenntag) were embedded into agar-
paraffin and subsequently stained with lumogallion for 24 h (as
with THP-1 cell sections) proved successful in positively
identifying both ABA as evidenced by an orange fluorescence
emission (Fig. 1).
Native THP-1 cells grown in R10 medium in the presence or
absence of AlO(OH)Sigma showed green autofluorescence in the
absence of the fluor lumogallion (Fig. 2a). Analysis of THP-1 cells
containing 200 mg/mL AlO(OH)Sigma revealed that those structures
identified produced clear DAPI fluorescence (Fig. 2b–c) confirming
the presence of nuclei and hence the positive identification of THP-1
cells. Overlaying of the light channel elucidated that the green auto-
fluorescence observed was most intense within the cell cytoplasm
(Fig. 2d).
In order to investigate whether AlO(OH)Sigma was taken up by
THP-1 cells, the cells were co-cultured in the presence or absence
of the ABA, sectioned and then stained with lumogallion.
Lumogallion staining of native THP-1 cells revealed a dull orange/
brown fluorescence for the cells (Fig. 3a) with DAPI fluorescence
confirming the presence of cell nuclei (Fig. 3b & c). Overlaying of the
light channel demonstrated that only cells were fluorescing with no
detectable fluorescence of the agar-support medium (Fig. 3d).
THP-1 cells co-cultured with 50 mg/mL of the AlO(OH)Sigma
adjuvant and stained with lumogallion, produced bright orange
fluorescence at their periphery (Fig. 3e) and clear DAPI fluorescence
(Fig. 3f).Merging of the fluorescence and light channels revealed that
the bright orange fluorescence of the AlO(OH)Sigma adjuvant (Fig. 3g,
magnified inset) was contained only within the cytoplasm of THP-1
cells (Fig. 3h). Extracellular ABA was readily identifiable for lumo-
gallion stained THP-1 cells co-cultured with 200 mg/mL
AlO(OH)Sigma (Fig. 3i). As with THP-1 cells co-cultured with
50 mg/mL AlO(OH)Sigma, spherical particulate-like structures were
identified intracellularly in THP-1 cells exhibiting DAPI fluor-
escence (Fig. 3j & k). The combination of light and fluorescence
channels depicted the clear localisation of an orange fluorescence
emission within cell cytoplasm and not within cell nuclei (Fig. 3l).
Spherical particulates of AlO(OH)Sigma identified intracellulary in
THP-1 cells proved to be consistent in size whether co-cultured with
50 or 200 mg/mL of the ABA. Spherical ABA particulates with an
average outer diameter of 0.88 6 0.17 mm and 0.90 6 0.14 mmwere
Figure 1 | Representative lumogallion fluorescence of agar-paraffin
embedded AlO(OH) adjuvants (2 mm sections). AlO(OH) sections were
incubated for 24 h in 50 mM PIPES, pH 7.4 containing 100 mM
lumogallion. Slides were mounted with FluoromountTM aqueous mounting
medium (Sigma Aldrich). (a). 200 mg/mL AlO(OH)Brenntag adjuvant, (b).
200 mg/mL AlO(OH)Sigma adjuvant. Magnification3 400, scale bars: 50 mm.
Figure 2 | Representative autofluorescence controls of agar-paraffin
embedded THP-1 cells (2 mm sections) co-cultured with 200 mg/mL
AlO(OH)Sigma adjuvant (24 h). Cell sections were incubated for 24 h in
50 mMPIPES, pH 7.4. Slides weremounted with ProLongHGold Antifade
Reagent with DAPI. Inserts show close-ups of individual cells. (a).
autofluorescence (green), (b). DAPI-staining (blue), (c). autofluorescence
& DAPI overlay, (d). autofluorescence, DAPI & light overlay.
Magnification 3 1000, scale bars: 20 mm.
www.nature.com/scientificreports
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observed (mean 6 SD, n 5 16) intracellulary in THP-1 cells co-
cultured in the presence of 50 and 200 mg/mL of the AlO(OH)Sigma
adjuvant, respectively (Table 1).
Identification of intracellular AlO(OH) particles in cryosectioned
THP-1 cells. We next examined whether the clinically approved
AlO(OH)Brenntag adjuvant was internalised in THP-1 cells co-
cultured in the presence or absence of 50 or 200 mg/mL of the
ABA via fluorescence microscopy. Analysis of cryo-sectioned
THP-1 cells showed a green autofluorescence of the cells with clear
DAPI fluorescence both in the presence or absence of the
AlO(OH)Brenntag adjuvant. For lumogallion stained native THP-1
cells cultured in the presence of R10 medium only, a dull orange/
brown fluorescence was observed (Fig. 4a). DAPI fluorescence
confirmed the presence of cell nuclei (Fig. 4b) which overlaid with
the lumogallion fluorescence (Fig. 4c) and light channels confirmed
the presence of a dull orange/brown fluorescence within the
cytoplasm of THP-1 cells (Fig. 4d).
Cryosectioned THP-1 cells co-cultured in the presence of 50 mg/
mL of the AlO(OH)Brenntag adjuvant and stained with lumogallion
revealed intracellular particulates of the ABA as identifiable by the
observed orange fluorescence emission (Fig. 4e). Overlay of the
DAPI fluorescence channel (Fig. 4f) confirmed that THP-1 cells
had internalised AlO(OH)Brenntag particulates, predominantly within
their cytoplasm with no evidence of ABA being present within cell
nuclei (Fig. 4g, magnified inset). Overlay of the light channel con-
firmed that positive lumogallion staining for ABA was only notable
within cell cytoplasm with little trace of extracellular ABA (Fig. 4h).
Similar observations were noted for THP-1 cells co-cultured in the
presence of 200 mg/mL AlO(OH)Brenntag, with a strong orange fluor-
escence emission being observed at the periphery (Fig. 4i) of posi-
tively identified THP-1 cells (Fig. 4j & k). Overlay of the light with the
lumogallion and DAPI fluorescence channels confirmed the pres-
ence of a strong orange fluorescence emission within the cell cyto-
plasm (Fig. 4l, magnified inset). Identification of individual
particulate-like structures was sometimes hindered due to the intense
orange fluorescence observed. Measurements of intracellular
AlO(OH)Brenntag particulates within THP-1 cells was however pos-
sible with cells co-cultured in 50 or 200 mg/mL of the ABA giving
average outer diameters of 1.09 6 0.23 mm and 1.00 6 0.10 mm
(mean 6 SD, n 5 16), respectively. The dimensions of intracellular
AlO(OH)Brenntag-based particulates was therefore in close agreement
to THP-1 cells co-cultured in the presence of the AlO(OH)Sigma
adjuvant (Table 1).
The complementary use of transmission electron microscopy
confirmed the presence of intracellular particulate AlO(OH)
adjuvant within THP-1 cells. To support any observations of
intracellular AlO(OH) particulates within THP-1 cells, cells co-
cultured in the presence or absence of the AlO(OH)Sigma adjuvant
Figure 3 | Representative lumogallion staining of agar-paraffin embedded (2 mm sections) native THP-1 cells (a–d), THP-1 cells co-cultured with
50 mg/mL AlO(OH)Sigma adjuvant (24 h) (e–h) & THP-1 cells co-cultured with 200 mg/mL AlO(OH)Sigma adjuvant (24 h) (i–l). Cell sections were
incubated for 24 h in 100 mMlumogallion, 50 mMPIPES, pH 7.4. Slides weremounted with ProLongHGold Antifade Reagent withDAPI. (a)., (e). & (i).
lumogallion staining (orange), (b)., (f). & (j). DAPI-staining (blue), (c)., (g). & (k). lumogallion & DAPI overlay, (d)., (h). & (l). lumogallion, DAPI &
light overlay. Inserts show close-ups of individual cells and white arrows highlight both individual and distinguishable adjuvant particles. Magnification
3 1000, scale bars: 20 mm.
Table 1 | Intracellular AlO(OH) particle sizes (outer diameter, OD) in THP-1 cells co-cultured with 50 or 200 mg/mL of either AlO(OH)Sigma
(1) or AlO(OH)Brenntag (2) adjuvant for 24 h. Cells were sectioned via three different methods: agar-paraffin sectioning, cryosectioning or
transmission electronmicroscopy (TEM). Visualisation of intracellular adjuvant particles for agar-paraffin and cryosectioned THP-1 cells was
achieved by fluorescent staining with lumogallion and for TEM by staining with 2% uranyl acetate. Particle sizes were determined by use of
the CellD software suite (Olympus) and mean particle size 6 SD are shown (n 5 16)
[AlO(OH)]/mg/mL
Intracellular AlO(OH) particle size (OD)/mm
(1)THP-1 Agar-paraffinSigma (2)THP-1 CryoBrenntag (1)THP-1 TEMSigma
50 0.88 6 0.17 1.09 6 0.23 1.04 6 0.35
200 0.90 6 0.14 1.00 6 0.10 1.20 6 0.26
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were embedded into resin and analysed by transmission electron
microscopy (TEM). TEM of native THP-1 cells cultured in R10
medium only allowed for the detection of cells (Fig. 5a) with clear
distinction between cell cytoplasm and nuclei (Fig. 5a–c). Native
THP-1 cells were found to have a dense granular cytoplasm with
the entire cell free of any particulate material (Fig. 5c).
For those cells co-cultured in the presence of 50 mg/mL of the
AlO(OH)Sigma adjuvant, electron dense particulates were observed
within the cytoplasm of THP-1 cells (Fig. 5d). Higher magnifications
revealed the presence of needle-like particulates (Fig. 5e & f) in
aggregates with an average size of 1.04 6 0.35 mm (mean 6 SD,
n 5 16) (Table 1). Those particulates observed were found to be
present in the cell cytoplasm only and contained within vesicle-like
structures.
THP-1 cells co-cultured with 200 mg/mL of the AlO(OH)Sigma
adjuvant revealed aggregated particulates of the ABA solely present
within the cell cytoplasm (Fig. 5g). Extracellular ABA was also found
within the agar support medium as with the lumogallion fluor-
escence analyses of the cells (Fig. 3i & Fig. 4i). Higher magnifications
revealed that internalised AlO(OH) particulates were found in ves-
icle-like structures (Fig. 5h & i) as with cells co-cultured in lower
concentrations of the ABA with an average size of 1.20 6 0.26 mm
(mean 6 SD, n 5 16) (Table 1). It was also noted that the cell
cytoplasm of THP-1 cells co-cultured in the presence of the ABA
(Fig. 5d& Fig. 5g) exhibited a loss of integrity in comparison to native
cells (Fig. 5a).
Confocal microscopy confirms the presence of intracellular
AlO(OH) in non-sectioned THP-1 cells. To ascertain whether
AlO(OH)Brenntag was internalised within THP-1 cells whilst avoid-
ing sectioning and the potential loss or disturbance of intracellular
particulates, cells cultured in the absence or presence of the ABA
were stained with lumogallion and analysed by confocal microscopy.
Cells were counter-stained with DAPI for the identification of cell
nuclei. Merging of both DAPI and lumogallion fluorescence chan-
nels for THP-1 cells co-cultured with 50 mg/mL AlO(OH)Brenntag
showed positive lumogallion staining for aluminium observed as
spherical particulates contained within the cytoplasm of cells with
a lack of particulate material localised in cell nuclei (see
Supplementary Fig. 1a). Merging of the two channels for native
THP-1 cells revealed positive DAPI staining only, confirming the
presence of cell nuclei (see Supplementary Fig. 1b).
Discussion
We have investigated whether a clinically approved AlO(OH)Brenntag
adjuvant and an experimental AlO(OH)Sigma adjuvant of similar for-
mulation can enter a monocytic THP-1 cell line. Whilst studies have
pertained to the presence of ABA inside APCs and cells of monocytic
origin, none have shown the unequivocal presence of intracellular
ABA6,12,15,21,29. A recent study has demonstrated the presence of in
vivo injected aluminium adjuvant in rat at amuscular as opposed to a
cellular level using lumogallion30. The direct identification of intra-
cellular particulates of AlO(OH)-based adjuvants were therefore
sought via the use of lumogallion as a sensitive molecular probe for
aluminium24,25. The use of lumogallion also ensured that aluminium
was detected inside cells as opposed to the identification ofmolecular
markers which in themselves may be internalised with antigen in the
absence of the attached ABA, or may have an influence upon their
cellular uptake.
It was not known whether lumogallion could bind to particulate
ABA to provide a characteristic fluorescence emission at ca 590 nm
(orange)28. Whilst easily distinguishable from the agar support med-
ium, those AlO(OH) particulates observed were found to fluoresce at
low intensity (Fig. 1). As AlO(OH) possesses a crystalline structure
with a degree of symmetry31, a high proportion of available alu-
minium sites (Al31) will be held internally forming crystal contacts,
thereby occluding their binding to lumogallion with only external
sites able to bind. In spite of these observations however both the
clinical and experimental AlO(OH) formulations could be detected.
To our knowledge this is the first report of the use of lumogallion for
the unequivocal detection of intracellular ABA.
For the investigation of the potential intracellular uptake of
AlO(OH), a cultured human THP-1 cell line of monocytic origin
was used in order to investigate a relevant in vitro model used in
separate reports of the effects of ABA on mitochondrial activity and
phagosomal pathways of phagocytosing cells32. Morin has previously
been used to detect internalised ABA conjugated to antigens11 via a
green fluorescence emission at ca 510 nm18. Therefore the establish-
Figure 4 | Representative lumogallion staining of cryosectioned (6 mm sections) native THP-1 cells (a–d), THP-1 cells co-cultured with 50 mg/mL
AlO(OH)Brenntag adjuvant (24 h) (e–h) & THP-1 cells co-cultured with 200 mg/mLAlO(OH)Brenntag adjuvant (24 h) (i–l).Cell sections were incubated for
24 h in 100 mM lumogallion, 50 mMPIPES, pH 7.4. Slides were mounted with ProLongHGold Antifade Reagent with DAPI. (a)., (e). & (i). lumogallion
staining (orange), (b)., (f). & (j). DAPI-staining (blue), (c)., (g). & (k). lumogallion & DAPI overlay, (d)., (h). & (l). lumogallion, DAPI & light overlay.
Inserts show close-ups of individual cells and white arrows highlight both individual and distinguishable adjuvant particles. Magnification 3 1000, scale
bars: 20 mm.
www.nature.com/scientificreports
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ment of autofluorescence of any given cell line is critical in order to
rule out the possibility of the green fluorescence signal observed
being attributable to the cellular components rather than that of
internalised ABA.
For the analysis of cell sections under the lumogallion fluorescence
channel, a long pass emission filter was used allowing emitted wave-
lengths of or greater than 510 nm to pass through hence explaining
the observed green autofluorescence for cells (Fig. 2). Due to the
aforementioned sensitivity issues of morin binding to divalent metal
ions to produce false positives, lumogallion provides an attractive
approach to the identification of ABA with high sensitivity at a
physiologically relevant pH.
A uniform orange fluorescence was observed for cells co-cultured
in the presence of AlO(OH) in regions of the cells found to be devoid
of particulate AlO(OH). The fluorescence observed was found to be
less intense than that of positively identified particulates (e.g. Fig. 4e)
but more intense than the dull orange/brown fluorescence observed
for native cells (e.g. Fig. 4a), likely explained by the use of a long pass
emission filter. Therefore we cannot rule out the possibility of soluble
Al31 being present within cell cytoplasm and/or nuclei, as inferred by
the lumogallion analyses. Particulates for both the clinically
approved and experimental AlO(OH) formulations were localised
within the cell cytoplasm of THP-1 cells. These observations were
supported via TEM in which particulate AlO(OH)Sigma was localised
within vesicle-like structures in the cytoplasm of THP-1 cells only
(Fig. 5), in similar size aggregates of ca 1 mm (Table 1).
Fluorescence microscopy and TEM both required cells to be sec-
tioned to allow for the exposure of intracellular AlO(OH) to lumo-
gallion and uranyl acetate, respectively. To rule out the possibility of
particulate AlO(OH) being observed in THP-1 cells as a result of
artefacts arising from the sectioning and embedding procedures33,
confocal microscopy of whole cells was performed. Confocal micro-
scopy of living cells stained with lumogallion demonstrated the pres-
ence of particulate AlO(OH) within the cell cytoplasm only thereby
confirming that ABAwere deposited intracellularly and did not arise
from extracellular particulates being deposited on the surface of
newly exposed cell sections (see Supplementary Fig. 1).
Research investigating the phagosomal pathways of THP-1 cells in
the presence of AlO(OH) implicated that phagocytosis of particulate
ABA results in the entrapment of particulate ABA in phagosomes32.
It was concluded that the subsequentmaturation of phagosomes into
phagolysosomes resulted in the acidification of their interior causing
the pH to fall to ca 4.5 to 5. Under these acidic conditions it is likely
that the solubility of the internalised ABA will be increased32 result-
ing in the greater availability of intracellular Al31. Interestingly, for
the unequivocal identification of intracellular AlO(OH) demon-
strated herein, a more intense orange fluorescence emission was
observed for intracellular versus extracellular ABA particulates
(e.g., Fig. 3e & 4i). As lumogallion is known to bind 151 with Al31
a greater availability of the metal ion would result in increased com-
plex formation, thereby explaining the intense fluorescence observed
for intracellular AlO(OH). Our results therefore support the pha-
gocytosis of ABAs by monocytic cells.
A study investigating the uptake of ovalbumin adsorbed onto the
surface of alpha aluminium oxide nanoparticles (a-Al2O3-OVA) by
DCs showed electron dense particles internalised within autophago-
somes and autlolysosomes by TEM21. Those aggregates observed
were found to be ca 1 mm in size21 and therefore in the same size
range for intracellular AlO(OH) shown herein. These results taken
together suggest that the intracellular uptake of ABA by cells of
monocytic origin, occurs via phagocytotic mechanisms21,32. Within
this research we have shown that lumogallion provides an excellent
molecular probe for ABA, allowing for the fate of ABA to be deter-
mined in a relevant in vitro cell line32.
The adsorption of inherent antigen in the form of serum proteins
including bovine serum albumin included in the 10% foetal calf
serum used for cell culture, may have affected the uptake of the
AlO(OH) adjuvants used within this study. Further studies are cur-
Figure 5 | Representative electron micrographs from TEM of Spurr resin-sectioned (100 nm sections) native THP-1 cells (a–c), THP-1 cells
co-cultured with 50 mg/mL AlO(OH)Sigma adjuvant (24 h) (d–f) & THP-1 cells co-cultured with 200 mg/mL AlO(OH)Sigma adjuvant (24 h) (g–i). Cell
resin-sections were stained for 20 min with 2% ethanolic uranyl acetate, rinsed with 30% ethanol followed by ultrapure water and finally allowed 24 h
drying time prior to analysis via TEM. Inserts show close-ups of intracellular adjuvant particles containedwithin vesicle-like structures and the red arrows
highlight their presence within the respective cell images. Magnification & scale bars: (a)., (d). & (g). 3 8 K, 5 mm, (b)., (e). & (h).3 20 K, 2 mm, (c)., (f).
& (i). 3 30 K, 1 mm, respectively.
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rently underway to address the influences of co-adsorbed antigens on
the cellular uptake of aluminium adjuvants. In addition we now aim
to ascertain whether internalised aluminium adjuvant has antigen
associated with it. The unequivocal identification of intracellular
ABA may prove essential for the understanding of the adjuvanticity
of ABAs administered in human vaccinations.
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